News Archives

News Archives

Avivagen Announces Grant Of Stock Options

Ottawa, ON / TNW-Accesswire / May 30, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF), a life sciences company commercializing products to replace the antibiotics used in livestock feeds, is accelerating market access and the commercial uptake of its OxC-beta™ Livestock product, an innovative product that has the potential to eliminate the use …Read More

Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.

Significant increase in the magnitude of the purchase order Ottawa, ON / TNW-Accesswire / May 26, 2017 / – Avivagen Inc. (TSXV: VIV, OTC Pink: CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces a third …Read More

Avivagen Announces Completion of Share Consolidation and Issuance of 2nd Quarter Results

Ottawa, ON / TNW-Accesswire / May 24, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that, following the approval of the Corporation’s shareholders obtained April 11, 2017, the Corporation …Read More

Avivagen Announces Engagement of Regulatory Consulting Firm

Ottawa, ON / TNW-Accesswire / May 12, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces the hiring of a regulatory consulting firm to work with the Corporation to analyze …Read More

Avivagen Inc. Announces Consolidation of Common Shares

Ottawa, ON / TNW-Accesswire / May 8, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that it intends to effect a 10 to 1 consolidation (the “Consolidation”) of its …Read More

Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017

Ottawa, ON / TNW-Accesswire / April 26, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters announces that it will be presenting at the Bloom Burton & Co. Healthcare Investor Conference …Read More